Literature DB >> 29484737

The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies.

Xiu-Fen Liu1, Ji-Long Hao1, Tian Xie2, Om Prakash Pant1, Cheng-Bo Lu3, Cheng-Wei Lu1, Dan-Dan Zhou4.   

Abstract

Long non-coding RNAs (lncRNAs) participate in the complex network of cancer and play an important role in tumourigenesis and progression. BRAF activated non-coding RNA (BANCR), a 4-exon transcript of 693-bp, was first discovered as an oncogenic long non-coding RNA in BRAFV600E melanomas cells in 2012 and was related to melanoma cell migration. Besides melanoma, increasing evidence has explored the potential role of BANCR in the development and progression of multiple other human malignancies, such as retinoblastoma, lung cancer, gastric cancer etc. since its discovery. The expression pattern of BANCR varies in different types of cancers, either as a tumour suppressor or as an accelerator. Functional BANCR may serve as a promising biomarker for cancer diagnosis as well as prognosis evaluation. BANCR-targeted intervention may also become a valuable novel therapeutic tool against human malignancies. This review summarized the advanced research progresses concerning the expression and role of BANCR in different human malignancies.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990BANCRzzm321990; long noncoding RNAs (lncRNAs); tumour accelerator; tumour suppressor

Mesh：

Substances：

Year:  2018        PMID： 29484737      PMCID： PMC6528848          DOI： 10.1111/cpr.12449

Source DB:  PubMed          Journal:  Cell Prolif        ISSN： 0960-7722            Impact factor:   6.831


  55 in total

Review 1.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

Review 2.  Retinoblastoma.

Authors:  Alex Melamud; Rakhee Palekar; Arun Singh
Journal:  Am Fam Physician       Date:  2006-03-15       Impact factor: 3.292

3.  Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

Authors:  Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Hu-Liang Jia; Ping He; Krista A Zanetti; Udai S Kammula; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Cell       Date:  2006-08       Impact factor: 31.743

Review 4.  The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies.

Authors:  Xiu-Fen Liu; Ji-Long Hao; Tian Xie; Om Prakash Pant; Cheng-Bo Lu; Cheng-Wei Lu; Dan-Dan Zhou
Journal:  Cell Prolif       Date:  2018-02-27       Impact factor: 6.831

5.  Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε.

Authors:  Y-H Fan; M-H Ye; L Wu; S-G Lv; M-J Wu; B Xiao; C-C Liao; Q-K Ji; Y Chai; X-G Zhu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-10       Impact factor: 3.507

6.  Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

7.  The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.

Authors:  Jinyu Yu; Junqing Han; Jian Zhang; Guanzhen Li; Hui Liu; Xianping Cui; Yantian Xu; Tao Li; Juan Liu; Chuanxi Wang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 8.  BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis.

Authors:  Yang-Hua Fan; Min-Hua Ye; Lei Wu; Miao-Jing Wu; Shi-Gang Lu; Xin-Gen Zhu
Journal:  Oncotarget       Date:  2017-01-24

9.  BRAF-Activated Long Noncoding RNA Modulates Papillary Thyroid Carcinoma Cell Proliferation through Regulating Thyroid Stimulating Hormone Receptor.

Authors:  Haitao Zheng; Meng Wang; Lixin Jiang; Haidi Chu; Jinchen Hu; Jinyao Ning; Baoyuan Li; Dong Wang; Jie Xu
Journal:  Cancer Res Treat       Date:  2015-08-12       Impact factor: 4.679

10.  BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.

Authors:  Tian Liao; Ning Qu; Rong-Liang Shi; Kai Guo; Ben Ma; Yi-Ming Cao; Jun Xiang; Zhong-Wu Lu; Yong-Xue Zhu; Duan-Shu Li; Qing-Hai Ji
Journal:  Oncotarget       Date:  2017-01-03
View more
  10 in total

1.  Resveratrol improves high-fat diet-induced insulin resistance in mice by downregulating the lncRNA NONMMUT008655.2.

Authors:  Linyi Shu; Guangsen Hou; Hang Zhao; Wenli Huang; Guangyao Song; Huijuan Ma
Journal:  Am J Transl Res       Date:  2020-01-15       Impact factor: 4.060

2.  lncRNA DLEU1 Modulates Proliferation, Inflammation, and Extracellular Matrix Degradation of Chondrocytes through Regulating miR-671-5p.

Authors:  Xiangkun Wu; Shuai Yin; Lihua Yan; Yongxi Liu; Lilin Shang; Jun Liu
Journal:  J Immunol Res       Date:  2022-05-18       Impact factor: 4.493

Review 3.  The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies.

Authors:  Xiu-Fen Liu; Ji-Long Hao; Tian Xie; Om Prakash Pant; Cheng-Bo Lu; Cheng-Wei Lu; Dan-Dan Zhou
Journal:  Cell Prolif       Date:  2018-02-27       Impact factor: 6.831

4.  Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis.

Authors:  Xin Mu; Kuan-Hou Mou; Rui Ge; Dan Han; Yan Zhou; Li-Juan Wang
Journal:  Int J Oncol       Date:  2019-07-25       Impact factor: 5.650

5.  Competing endogenous network analysis identifies lncRNA Meg3 activates inflammatory damage in UVB induced murine skin lesion by sponging miR-93-5p/epiregulin axis.

Authors:  Nan Zhang; Zhou Zhong; Yujia Wang; Li Yang; Fengbo Wu; Cheng Peng; Wei Huang; Gu He
Journal:  Aging (Albany NY)       Date:  2019-11-24       Impact factor: 5.682

6.  Downregulation of long non-coding RNA B-Raf proto-oncogene-activated non-coding RNA reverses cisplatin resistance in laryngeal squamous cell carcinoma.

Authors:  Weiwei Han; Lin Niu; Lin Wang; Jixiang Liu; Huanying Li
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

7.  Expression of SOX2OT, DANCR and TINCR long non‑coding RNAs in papillary thyroid cancer and its effects on clinicopathological features.

Authors:  Fadime Mutlu Icduygu; Egemen Akgun; Demet Sengul; Asuman Ozgoz; Ebru Alp
Journal:  Mol Med Rep       Date:  2022-02-11       Impact factor: 2.952

8.  LncRNA BANCR Promotes Endometrial Stromal Cell Proliferation and Invasion in Endometriosis via the miR-15a-5p/TRIM59 Axis.

Authors:  Lixue Liu; Ru Bai; Debang Li; Bai Dai; Ya Tuo
Journal:  Int J Genomics       Date:  2022-10-10       Impact factor: 2.758

9.  Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.

Authors:  Sheng Xue; Sheng-Qun Jiang; Qing-Wen Li; Sheng Wang; Jian Li; Shuai Yang; Hai-Min Zhang; Yun-Fei Xu; Long-Sheng Wang; Jun-Hua Zheng
Journal:  BMC Urol       Date:  2018-09-10       Impact factor: 2.264

10.  Comparative analysis of long non‑coding RNA expression profiles induced by resveratrol and metformin treatment for hepatic insulin resistance.

Authors:  Linyi Shu; Xiaoyu Hou; Guangyao Song; Chao Wang; Huijuan Ma
Journal:  Int J Mol Med       Date:  2021-09-28       Impact factor: 4.101
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.